Back to Dividend Stocks
Viatris Inc. (VTRS) logo

Viatris Inc.

S&P 500
VTRS|Healthcare|Drug Manufacturers - Specialty & Generic|$17.17|P/E 235.8|MCap 20.0B|NASDAQ

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

38/ 100Warning

VTRS's dividend shows several warning signs. Strengths include a 30.3% fcf payout ratio & 1.6x current ratio. Areas of concern: 960.0% earnings payout ratio & 72.6% cfo payout ratio.

Based on 15 of 15 metrics

Strengths

  • FCF Payout Ratio: 30.3%Free cash flow comfortably covers the dividend.
  • Dividend Cut: NoneNo dividend cut in recent history.
  • Current Ratio: 1.6xStrong short-term liquidity to meet obligations.

Risks

  • Earnings Payout Ratio: 960.0%High earnings payout ratio leaves little safety margin.
  • Interest Coverage: -6.8xInterest coverage is thin relative to debt servicing.
  • Return on Equity: -2.0%Return on equity is below industry norms.

Payout & Coverage

Warning
Earnings Payout Ratio
960.0%Danger
FCF Payout Ratio
30.3%Very Safe
CFO Payout Ratio
72.6%Warning
Interest Coverage
-6.8xDanger

Balance Sheet

Safe
Net Debt / Total Assets
36.0%Caution
Current Ratio
1.6xSafe
Debt-to-Equity
97.9Safe

Profitability

Warning
Return on Equity
-2.0%Danger
Operating Margin
-0.6%Danger
Gross Margin
31.0%Caution
Profit Margin Stability
UnstableDanger

Dividend Track Record

Caution
Dividend Streak
5+ yrsCaution
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
0.0%Warning
Earnings Stability
UnstableDanger

About Viatris Inc.

Viatris Inc. is a global healthcare company that develops, manufactures, and markets a broad portfolio of branded and generic pharmaceutical products. It specializes in generics, including commoditized and complex varieties as well as biosimilars, alongside legacy branded medicines such as Lipitor, Norvasc, Lyrica, and Viagra. The company addresses multiple therapeutic areas, including cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare, with particular focus on dermatology, ophthalmology, and gastroenterology. Viatris Inc. serves patients in over 165 countries through its extensive product offerings in the specialty and generic drug sectors. Founded in 2019 and headquartered in Canonsburg, Pennsylvania, it operates as one of the largest generic drug manufacturers worldwide, providing essential medicines and treatments to diverse healthcare markets.

Dividend Overview

Dividend Yield

2.79%

Annual Dividend

$0.48

Frequency

Quarterly

Payout Ratio

960.00%

FCF Payout Ratio

30.32%

Stock Price

$17.17

52-Week Range

$8.19 $17.53

Dividend History (2016–2025)

VTRS annual dividend per share and yield history

Earnings & Profitability

VTRS earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

May 22, 2026

Next Payment Date

June 17, 2026

Dividend Growth

3-Year Dividend CAGR

0.00%

5-Year Dividend CAGR

0.00%

10-Year Dividend CAGR

0.00%

3-Year Total Growth

0.00%

5-Year Total Growth

0.00%

10-Year Total Growth

0.00%

Income Calculator

VTRS Dividend Calculator

Total Investment

$1,717.00

Annual Income

$48.00

Quarterly Income

$12.00

Monthly Income

$4.00

Similar Dividend Stocks

StockYield5Y CAGRPrice
Viatris Inc. (VTRS) logo
VTRS
2.79%0.00%$17.17
Baxter International Inc. (BAX) logo
BAX
2.00%-11.45%$17.99
Moderna, Inc. (MRNA) logo
MRNA
0.00%N/A$54.35

Frequently Asked Questions

What is VTRS's current dividend yield?
Viatris Inc. (VTRS) currently has a dividend yield of 2.79%, based on a stock price of $17.17 and an annual dividend of $0.48.
When is VTRS's next dividend payment date?
VTRS's next ex-dividend date is 2026-05-22 and the next payment date is 2026-06-17. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does VTRS pay in dividends per year?
Viatris Inc. paid $0.48 per share in annual dividends in 2025. The dividends are paid quarterly.
Has VTRS been increasing its dividend?
Viatris Inc. has grown its dividend at a 5-year CAGR of 0.00% and a 10-year CAGR of 0.00%.
Is VTRS's dividend safe?
Viatris Inc. has a payout ratio of 960.00%. Its free cash flow payout ratio is 30.32%. The payout ratio is above 100%, which may indicate the company is paying more in dividends than it earns. This could be unsustainable long-term.
How is VTRS's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Viatris Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track VTRS Dividends with OnlyDividends

What will VTRS actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.